25 research outputs found
The Ly-6A (Sca-1) GFP transgene is expressed in all adult mouse hematopoietic stem cells
The Sca-1 cell surface glycoprotein is used routinely as a marker of adult
hematopoietic stem cells (HSCs), allowing a >100-fold enrichment of these
rare cells from the bone marrow of the adult mouse. The Sca-1 protein is
encoded by the Ly-6A/E gene, a small 4-exon gene that is tightly
controlled in its expression in HSCs and several hematopoietic cell types.
For the ability to sort and localize HSCs directly from the mouse, we
initiated a transgenic approach in which we created Ly-6A (Sca-1) green
fluorescent protein (GFP) transgenic mice. We show here that a 14-kb Ly-6A
expression cassette directs the transcription of the GFP marker gene in
all functional repopulating HSCs in the adult bone marrow. A >100-fold
enrichment of HSCs occurred by sorting for the GFP-expressing cells.
Furthermore, as shown by fluorescence-activated cell sorting and
histologic analysis of several hematopoietic tissues, the GFP transgene
expression pattern generally corresponded to that of Sca-1. Thus, the
Ly-6A GFP transgene facilitates the enrichment of HSCs and presents the
likelihood of identifying HSCs in situ
Gata3 targets Runx1 in the embryonic haematopoietic stem cell niche.
Runx1 is an important haematopoietic transcription factor as stressed by its involvement in a number of haematological malignancies. Furthermore, it is a key regulator of the emergence of the first haematopoietic stem cells (HSCs) during development. The transcription factor Gata3 has also been linked to haematological disease and was shown to promote HSC production in the embryo by inducing the secretion of important niche factors. Both proteins are expressed in several different cell types within the aorta-gonads-mesonephros (AGM) region, in which the first HSCs are generated; however, a direct interaction between these two key transcription factors in the context of embryonic HSC production has not formally been demonstrated. In this current study, we have detected co-localisation of Runx1 and Gata3 in rare sub-aortic mesenchymal cells in the AGM. Furthermore, the expression of Runx1 is reduced in Gata3 -/- embryos, which also display a shift in HSC emergence. Using an AGM-derived cell line as a model for the stromal microenvironment in the AGM and performing ChIP-Seq and ChIP-on-chip experiments, we demonstrate that Runx1, together with other key niche factors, is a direct target gene of Gata3. In addition, we can pinpoint Gata3 binding to the Runx1 locus at specific enhancer elements which are active in the microenvironment. These results reveal a direct interaction between Gata3 and Runx1 in the niche that supports embryonic HSCs and highlight a dual role for Runx1 in driving the transdifferentiation of haemogenic endothelial cells into HSCs as well as in the stromal cells that support this process.This work was supported by an Intermediate Fellowship (K.O.) and a Junior Fellowship (S.R.F.) from the Kay Kendall Leukaemia Fund, a British Society for Haematology Early Stage Investigator Fellowship (K.O.) as well as funding from Bloodwise (N.K.W. and B.G.), MRC (N.K.W. and B.G.) and the Wellcome Trust (N.K.W. and B.G.). MdB is funded by a programme in the MRC Molecular Hematology Unit Core award (Grant number: MC_UU_12009/2). Core facilities are supported by Strategic Award WT100140, equipment grant 093026 and centre grant MR/K017047/1
Embryonal subregion-derived stromal cell lines from novel temperature-sensitive SV40 T antigen transgenic mice support hematopoiesis
Throughout life, the hematopoietic system requires a supportive
microenvironment that allows for the maintenance and differentiation of
hematopoietic stem cells (HSC). To understand the cellular interactions
and molecules that provide these functions, investigators have previously
established stromal cell lines from the late gestational stage and adult
murine hematopoietic microenvironments. However, the stromal cell
microenvironment that supports the emergence, expansion and maintenance of
HSCs during mid-gestational stages has been largely unexplored. Since
several tissues within the mouse embryo are known to harbor HSCs (i.e.
aortagonads-mesonephros, yolk sac, liver), we generated numerous stromal
cell clones from these mid-gestational sites. Owing to the limited cell
numbers, isolations were performed with tissues from transgenic embryos
containing the ts SV40 Tag gene (tsA58) under the transcriptional control
of constitutive and ubiquitously expressing promoters. We report here that
the growth and cloning efficiency of embryonic cells (with the exception
of the aorta) is increased in the presence of the tsA58 transgene.
Furthermore, our results show that the large panel of stromal clones
isolated from the different embryonal subregions exhibit heterogeneity in
their ability to promote murine and human hematopoietic differentiation.
Despite our findings of heterogeneity in hematopoietic growth factor gene
expression profiles, high-level expression of some factors may influence
hematopoietic differentiation. Interestingly, a few of these stromal
clones express a recently described chordin-like protein, which is an
inhibitor of bone morphogenic proteins and is preferentially expressed in
cells of the mesenchymal lineage
Signaling from the Sympathetic Nervous System Regulates Hematopoietic Stem Cell Emergence during Embryogenesis
SummaryThe first adult-repopulating hematopoietic stem cells (HSCs) emerge in the aorta-gonads-mesonephros (AGM) region of the embryo. We have recently identified the transcription factor Gata3 as being upregulated in this tissue specifically at the time of HSC emergence. We now demonstrate that the production of functional and phenotypic HSCs in the AGM is impaired in the absence of Gata3. Furthermore, we show that this effect on HSC generation is secondary to the role of Gata3 in the production of catecholamines, the mediators of the sympathetic nervous system (SNS), thus making these molecules key components of the AGM HSC niche. These findings demonstrate that the recently described functional interplay between the hematopoietic system and the SNS extends to the earliest stages of their codevelopment and highlight the fact that HSC development needs to be viewed in the context of the development of other organs
Genome-wide Analysis of Simultaneous GATA1/2, RUNX1, FLI1, and SCL Binding in Megakaryocytes Identifies Hematopoietic Regulators
SummaryHematopoietic differentiation critically depends on combinations of transcriptional regulators controlling the development of individual lineages. Here, we report the genome-wide binding sites for the five key hematopoietic transcription factorsâGATA1, GATA2, RUNX1, FLI1, and TAL1/SCLâin primary human megakaryocytes. Statistical analysis of the 17,263 regions bound by at least one factor demonstrated that simultaneous binding by all five factors was the most enriched pattern and often occurred near known hematopoietic regulators. Eight genes not previously appreciated to function in hematopoiesis that were bound by all five factors were shown to be essential for thrombocyte and/or erythroid development in zebrafish. Moreover, one of these genes encoding the PDZK1IP1 protein shared transcriptional enhancer elements with the blood stem cell regulator TAL1/SCL. Multifactor ChIP-Seq analysis in primary human cells coupled with a high-throughput in vivo perturbation screen therefore offers a powerful strategy to identify essential regulators of complex mammalian differentiation processes
High-level Gpr56 expression is dispensable for the maintenance and function of hematopoietic stem and progenitor cells in mice
AbstractBlood formation by hematopoietic stem cells (HSCs) is regulated by a still incompletely defined network of general and HSC-specific regulators. In this study, we analyzed the role of G-protein coupled receptor 56 (Gpr56) as a candidate HSC regulator based on its differential expression in quiescent relative to proliferating HSCs and its common targeting by core HSC regulators. Detailed expression analysis revealed that Gpr56 is abundantly expressed by HSPCs during definitive hematopoiesis in the embryo and in the adult bone marrow, but its levels are reduced substantially as HSPCs differentiate. However, despite enriched expression in HSPCs, Gpr56-deficiency did not impair HSPC maintenance or function during steady-state or myeloablative stress-induced hematopoiesis. Gpr56-deficient HSCs also responded normally to physiological and pharmacological mobilization signals, despite the reported role of this GPCR as a regulator of cell adhesion and migration in neuronal cells. Moreover, Gpr56-deficient bone marrow engrafted with equivalent efficiency as wild-type HSCs in primary recipients; however, their reconstituting ability was reduced when subjected to serial transplantation. These data indicate that although GPR56 is abundantly and selectively expressed by primitive HSPCs, its high level expression is largely dispensable for steady-state and regenerative hematopoiesis